Loratadine Allergy Relief Tablet
NDC Package 51660-526-30
Package Information
Loratadine Allergy Relief (loratadine) tablets is adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hourschildren under 6 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor. This formulation utilizes a tablet delivery system. Marketed by Ohm Laboratories Inc., this product is identified by NDC 51660-526 and is authorized under FDA application ANDA076134.
Identification & Billing
- RxCUI: 311372 - loratadine 10 MG 24HR Oral Tablet
- RxCUI: 311372 - loratadine 10 MG Oral Tablet
- RxCUI: 311372 - loratadine 10 MG 24 HR Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51660 - Ohm Laboratories Inc.
- 51660-526 - Loratadine Allergy Relief
- 51660-526-30 - 30 TABLET in 1 BOTTLE
- 51660-526 - Loratadine Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51660-526). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51660-526-30 identifies a specific commercial package of 30 tablet in 1 bottle of Loratadine Allergy Relief, a human over the counter drug labeled by Ohm Laboratories Inc.. This tablet is formulated for oral use and contains loratadine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Laboratories Inc. on November 01, 2017. The current certification is valid through December 31, 2026.
How is this Ohm Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51660052630. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.